An epidemiological and genetic investigation of myotonia congenita was carried out in northern Finland. Altogether 58 patients were identified (of whom 54 lived in the study area) in 23 families, with a prevalence of 7.3 per 100 000. The majority of the families originated from a sparsely populated area in western Lapland.
Myotonia congenita (MC) is a non-dystrophic hereditary disease of skeletal muscle. MC can be inherited as an autosomal recessive trait (Becker's disease), as first described by Leyden,' or as an autosomal dominant trait (Thomsen's disease).2 In both forms of MC, the characteristic clinical feature is myotonia, starting in early childhood. Myotonia is based on an electrical instability of the muscle membrane, suggested to be a direct consequence of a reduced chloride ion conductance in the tubular system of muscle fibres.3 During the first years the myotonic stiffness progresses slowly, but eventually affects the whole skeletal musculature. 4 Myotonia is most severe during voluntary muscle activity following a period of rest. Another typical feature of the disease is variable muscle hypertrophy. Studies on MC patients5 6 have shown that the overall output of motor performance in the patients does not seem to be greatly impaired.
Recently, both the autosomal dominant and the autosomal recessive forms of the disease have been associated with mutations in the muscle chloride channel protein gene in human chromosome region 7q35. 3 The mode of inheritance has also been questioned in some families, as the same mutation has been shown to lead to congenital myotonia in both heterozygous and homozygous forms. 3 In previous epidemiological studies,4 7 the prevalence of the disease has been reported to range from 0.2 to 0.9 per 100 000. In Germany, the prevalence of autosomal recessive myotonia was reported as 0.3 per 100 000 and of autosomal dominant myotonia 0.2 per 100 000, respectively. 4 This study aimed to clarify the epidemiology and genetics of MC in northern Finland. The clinical findings will be reported separately.
Patients and methods
The study area consisted of the provinces of Oulu and Lapland and the northern part of the province of Vaasa, with a total population of 732 000. The basic family material consisted of the families seen at the Departments of Neurology and Clinical Genetics at the Oulu University Hospital. Additional patients were ascertained retrospectively from hospital records and registers of Oulu University Hospital and the central hospitals of Kajaani, Kokkola, Kemi, and Rovaniemi, from the years 1974 to 1995. Furthermore, a call for patients with myotonic symptoms was addressed to the neurologists, paediatric neurologists, and general practitioners in the area of the investigation. The obtainable first degree relatives (healthy sibs included) were studied for microsymptoms, both clinically and electrophysiologically, in order to exclude or verify signs of myotonia.
The clinical diagnostic and inclusion criteria for the disease were as follows: muscle stiffness, muscle function improving with continuing exercise (action myotonia), variable muscle hypertrophy, and myotonic bursts on intramuscular electromyography (EMG) . The clinical criteria are in accordance with those set out by the European Neuromuscular Centre Workshop. 8 All the patients underwent a careful neurological and EMG examination. Genetic studies included family history and, in selected cases, tracing of common ancestors with the help of church records.
For the prevalence estimate, all patients living in the study area in 1995 were included. The evaluation of onset of the disease was based on the history given by the patients or their parents or both.
The study protocol was approved by the Ethics Committee of the Medical Faculty, per 100 000 from the city of Turin, Italy, was reported.
In our study the sex ratio was 2.2:1.0 in favour of males. In the German study of Becker,4 it was assumed that, in the dominant form of the disease, the sex ratio is approximately even and in the recessive form a slight preponderance of male patients was found.
Our results indicate that the disease is clearly more common in men than in women. The reason for this is unknown.
The mean age at onset of myotonia as reported by our patients or their parents was 1 4 The rapid development of neurological diagnostics during the last decades has shortened the delay in reaching a diagnosis, as seen also in the present material. Even when vertical transmission of the disease was seen in several families, autosomal recessive inheritance seems the most plausible mechanism to explain most of the familial occurrence of the disease. In the largest pedigree (A), several instances of parental consanguinity could be shown to explain the occurrence of the disease, both in parents and their children. It is also possible that a mutation(s) prevails in the population which allows the disease to become manifest in heterozygous and homozygous forms.'0 Molecular studies that are in progress should explain the genetic features of this exceptional prevalence of the disease in northern Finland.
We conclude that MC is unusually frequent in northern Finland, most probably as a consequence of enrichment of the gene(s) in the population.
